NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Actio Biosciences

Actio Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://actiobiosciences.com/

Last Round

Series B

Jun 18, 2025

Total Funding Raised

$137M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Actio Biosciences is a biotechnology company that develops precision medicines targeting the underlying genetic biology of rare diseases with potential applications for more prevalent indications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision medicinebiotechrare diseasedrug discoveryclinical trialsmall moleculepediatric epilepsytherapeutic candidatebioinformaticsdrug developmentorphan drugbiopharmagenetic disorderpreclinical researchclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Actio Biosciences Comparables

Compare Actio Biosciences with similar companies based on industry and business-model similarity.

Actio Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IAMA Therapeutics
79%
Praxis Precision Medicines, Inc.
79%
Atalanta Therapeutics
73%

Actio Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 18, 2025
Series ASep 12, 2023
SeedMay 1, 2022
SeedOct 1, 2021

Key People

Founding team and executive leadership

Cayce Denton

Chief Financial Officer

Executive Team

Sunil Sahdeo

Chief Operating Officer

Executive Team

Actio Biosciences Investors

Notable investors and investment history

Actio Biosciences investors
InvestorRounds
EcoR1 CapitalSeed, Series A
Deerfield ManagementSeed, Series A, Series B
Droia VenturesSeries A, Series B
Canaan PartnersSeries B, Series A
Euclidean CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 31% MoM.

  • Jan 7, 2026

    Presenting at the 44th Annual J.P. Morgan Healthcare Conference.

Actio Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Actio Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Actio Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range41
Year Founded2021
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.